CLINICAL DERMATOLOGY

‘Remission’: Novel psoriasis drug results ‘unheard of’

Gottingen, Germany — New research suggests that the experimental drug briakinumab — withdrawn from the U.S. regulatory approval process earlier this year — is more effective in treating psoriasis than methotrexate, although use of the new drug may carry higher risks. » More

ONCOLOGY

Narrower excision margins safe in melanoma

Stockholm — Researchers here say a 2 cm surgical excision margin is safe for patients with a stage IIA-C cutaneous melanoma thicker than 2 mm. » More

COSMETIC DERMATOLOGY

Botox sales rise, despite Europe’s economic woes

Irvine, Calif. — The top executive of Botox-maker Allergan says he’s “very favorably surprised” that the drug’s sales figures are growing rapidly in Europe despite economic woes there. » More

FYI ...

75%

Percentage of psoriasis patients who develop the condition by age 40

Source: American Academy of Dermatology

FACE TRANSPLANT

Chimp attack victim’s new face called ‘beautiful’

London — Charla Nash, the Connecticut woman who received the world’s second total face transplant earlier this year following a savage attack by a friend’s pet chimpanzee in 2009, spoke publicly about her ordeal for the first time in a British TV documentary, London’s Daily Express reports. » More

New Job Opportunities

All Island Dermatology		Arizona Skin & Laser
Arizona Skin & Laser		Center for Dermatology Care
Cynthia Dreyer MD		Dr. Dennis Gross
David A High MD		Mark Burnett MD
MedDerm Associates		Mosaic Clinic: Dermatology
Ochsner Health System		Richard G. Glogau
Universal Dermatology

Tools

•	Information Technology
•	Meetings & Events
•	Practice Management
•	Resource Centers

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.